Biblio Discovery — Demo Discovery Service

7 results for "Lin-Rui Gao"

Showing 1–7 · 0.00 seconds · RSS

  1. Journal Article

    VIRMA/IGF2BP3-mediated ANLN upregulation promotes intrahepatic cholangiocarcinoma growth by forming a positive feedback loop with RhoA/YAP1/TEAD1 signaling pathway

    Jiajun Zhang; Ning Huang; Lin-rui Gao et al.

    Cell Death and Disease, Vol. 17 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The prognosis of patients with intrahepatic cholangiocarcinoma (ICC) remains poor owing to the lack of effective targeted therapeutic strategies. Thus, the exploration of the molecular pathogenesis of ICC is urgently required. The cytoskeleton protein, anillin (ANLN), has been reported to…

  2. Journal Article

    Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma

    Pinli Yue; Fenglong Bie; Jiarun Zhu et al.

    Molecular Cancer, Vol. 23 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Accurate presurgical prediction of pathological complete response (pCR) can guide treatment decisions, potentially avoiding unnecessary surgeries and improving the quality of life for cancer patients. We developed a minimal residual disease (MRD) profiling approach with enhanced…

  3. Journal Article

    Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol

    Xiao Chang; Lei Deng; Wenjie Ni et al.

    BMC Cancer, Vol. 20 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background Currently, adjuvant therapy is not recommended for patients with thoracic esophageal squamous cell cancer (TESCC) after radical surgery, and a proportion of these patients go on to develop locoregional recurrence (LRR) within 2 years. Besides, there is no evidence for salvage…

  4. Journal Article

    A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

    Lin-rui Gao; Xin Wang; Weiming Han et al.

    BMC Cancer, Vol. 20 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background Since the development of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy (IMRT), no prospective study has investigated whether concurrent chemoradiotherapy (SIB-IMRT with 60 Gy) remains superior to radiotherapy (SIB-IMRT) alone for unresectable…

  5. Journal Article

    A nomogram for predicting the risk of chemoradiotherapy-associated thrombocytopenia in patients with esophageal cancer: a real-world cohort study

    Jia-Xuan Yang; Si-Yu Zuo; Jie Yang et al.

    Therapeutic Advances in Medical Oncology, Vol. 17 · 2025 · English · DOAJ Scopus

    Background: Thrombocytopenia is a common hematological toxicity in esophageal cancer (EC) patients receiving radiation therapy. Objectives: The purpose of this study was to construct and validate a nomogram for predicting the incidence of thrombocytopenia in EC patients receiving radiotherapy…

  6. Journal Article

    Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac

    Lin-Rui Gao; Yuan Tian; Ming-Shuai Wang et al.

    Frontiers in Oncology, Vol. 13 · 2023 · English · DOAJ Scopus

    ObjectiveTo quantitatively characterize the dosimetric effects of long on-couch time in prostate cancer patients treated with adaptive ultra-hypofractionated radiotherapy (UHF-RT) on 1.5-Tesla magnetic resonance (MR)-linac.Materials and methodsSeventeen patients consecutively treated with UHF-RT on…

  7. Journal Article

    Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy

    Lin-Rui Gao; Chen Li; Weiming Han et al.

    Therapeutic Advances in Medical Oncology, Vol. 14 · 2022 · English · DOAJ Scopus

    Objective: This study aimed to determine the long-term survival of patients with cT4 esophageal cancer (EC) and whether neoadjuvant chemoradiotherapy/radiotherapy plus surgery (nCRT/RT + S) is superior to definitive CRT(dCRT)/RT in terms of survival in cT4 EC downstaged after nCRT/RT. Summary…